Copyright
©The Author(s) 2016.
World J Transplant. Mar 24, 2016; 6(1): 115-124
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.115
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.115
Counterpulsation devices | |
EF | ↑ 5% |
BNP | < 500 pg/mL |
Continuous flow LVADs | |
LVEDD | < 60 mm |
LV end-systolic diameter | < 50 mm |
EF | > 45% |
LV end-diastolic pressure/PCWP | < 12 mmHg |
Cardiac Index (resting) | > 2.8 L/min per square |
Decrease |
Systolic aortic pressure |
End-diastolic aortic pressure |
LV systolic wall stress (afterload) |
Myocardial oxygen/LV energy consumption |
End-diastolic ventricular volume (preload) |
Mean pulmonary capillary wedge pressure |
Increase |
Diastolic aortic pressure (augmentation) |
LV mechanical performance (ejection fraction, stroke volume, cardiac output) |
LV contractility and active relaxation (in the reperfused failing heart) |
Coronary blood flow (post-ischemia, when coronary autoregulation is impaired and flow is pressure-dependent)[33] |
Cerebral, renal, mesenteric and pulmonary blood flow |
Mean arterial pressure (in patients with shock) |
Improves patients’ clinical status and their hemodynamic indices, rendering them suitable candidates for heart transplantation (BTT) |
Improves RV functionality and peripheral organ function, increasing the candidacy rates of patients who are illegible for additional mechanical interventions (BTC) |
Enhances native LV functional performance and unloads LV while maintaining its integrity, promoting reverse remodeling and cardiac recovery (BTR) |
- Citation: Kontogiannis CD, Malliaras K, Kapelios CJ, Mason JW, Nanas JN. Continuous internal counterpulsation as a bridge to recovery in acute and chronic heart failure. World J Transplant 2016; 6(1): 115-124
- URL: https://www.wjgnet.com/2220-3230/full/v6/i1/115.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i1.115